Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
The effect of statins on survival in patients with stage IV lung cancer
Jenny J. Lin
, Nicole Ezer
,
Keith Sigel
, Grace Mhango
, Juan P. Wisnivesky
Cancer Prevention & Control
Icahn School of Medicine at Mount Sinai
Medicine
Medicine - General Internal Medicine
Mount Sinai Tisch Cancer Center
CTSA ConduITS - Institutes for Translational Sciences
Graduate School of Biomedical Sciences
KL2
Medicine - Infectious Diseases
Research output
:
Contribution to journal
›
Article
›
peer-review
66
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The effect of statins on survival in patients with stage IV lung cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Statins
100%
Stage IV Non-small Cell Lung Cancer
100%
Statin Use
37%
Hazard Ratio
25%
Confidence Interval
25%
Anticancer Effect
25%
Lung Cancer-specific Survival
25%
Lung Cancer
12%
Patient Survival
12%
Median Survival
12%
Malignancy
12%
Chemotherapy
12%
Surveillance Epidemiology
12%
Propensity Score Analysis
12%
Patient Characteristics
12%
Biological Mechanisms
12%
Improved Survival
12%
Prospective Clinical Trial
12%
Lung Cancer Screening
12%
Medicare Claims
12%
Mortality Benefit
12%
Cancer Characteristics
12%
Propensity Score Methods
12%
Objective Prior
12%
Biological Test
12%
Pharmacology, Toxicology and Pharmaceutical Science
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Lung Cancer
100%
Statin (Protein)
57%
Non Small Cell Lung Cancer
42%
Cancer Specific Survival
28%
Malignant Neoplasm
14%
Clinical Trial
14%
Chemotherapy
14%